Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

SER consensus statement on the use of biologic therapy for systemic lupus erythematosus.

Calvo-Alén J, Silva-Fernández L, Úcar-Angulo E, Pego-Reigosa JM, Olivé A, Martínez-Fernández C, Martínez-Taboada V, Luis Marenco J, Loza E, López-Longo J, Gómez-Reino JJ, Galindo-Izquierdo M, Fernández-Nebro A, Cuadrado MJ, Aguirre-Zamorano MÁ, Zea-Mendoza A, Rúa-Figueroa I; Sociedad Española de Reumatología.

Reumatol Clin. 2013 Sep-Oct;9(5):281-96. doi: 10.1016/j.reuma.2013.04.001. Epub 2013 Jul 17. English, Spanish.

2.

[Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis].

Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-Reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Alvaro-Gracia JM, Martínez López JA, Loza Santamaría E.

Reumatol Clin. 2010 Jan-Feb;6(1):23-36. doi: 10.1016/j.reuma.2009.10.006. Epub 2009 Dec 6. Spanish.

3.

[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].

Gómez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Cañete JD, Collantes Estévez E, Fernández Carballido C, Fernández Sueiro JL, García de Vicuña R, González-Álvaro I, González Fernández C, Juanola X, Linares LF, Marenco JL, Martín Mola E, Moreno Ramos M, Mulero Mendoza J, Muñoz Fernández S, Queiro R, Richi Alberti P, Sanz J, Tornero Molina J, Zarco Montejo P, Carmona L; Sociedad Española de Reumatología.

Reumatol Clin. 2011 Sep-Oct;7(5):284-98. doi: 10.1016/j.reuma.2011.05.002. Epub 2011 Aug 4. Spanish.

4.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
5.

New biologic therapy for systemic lupus erythematosus.

Ding HJ, Gordon C.

Curr Opin Pharmacol. 2013 Jun;13(3):405-12. doi: 10.1016/j.coph.2013.04.005. Epub 2013 May 7. Review.

PMID:
23664092
6.

[2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis].

Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, García Vadillo A, Guañabens Gay N, Peris P, Torrijos Eslava A, Beltrán Audera C, Fiter Aresté J, Arboleya Rodríguez L, Graña Gil J, Carbonell Abelló J, Nolla JM, Holgado Pérez S, Salas Heredia E, Zubieta Tabernero J, Del Pino Montes J, Blanch i Rubió J, Caamaño Freire M, Rodríguez Pérez M, Castañeda S, Cerdá D, Gómez Vaquero C, Calvo Catalá J, Ciria M, Loza E; Spanish Society of Rheumatology.

Reumatol Clin. 2011 Nov-Dec;7(6):357-79. doi: 10.1016/j.reuma.2011.05.013. Epub 2011 Sep 15. Spanish.

7.

[Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].

Ramos-Casals M, Ruiz-Irastorza G, Jiménez-Alonso J, Khamashta MA; Comité de Consenso sobre el uso de belimumab, Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Sociedad Española de Medicina Interna (SEMI).

Rev Clin Esp (Barc). 2013 Jan-Feb;213(1):42-58. doi: 10.1016/j.rce.2012.10.004. Epub 2012 Dec 22. Spanish.

PMID:
23266125
8.

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T.

Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Review.

PMID:
22072024
9.

Biologic therapies in systemic lupus erythematosus.

Bernal CB, Zamora LD, Navarra SV.

Int J Rheum Dis. 2015 Feb;18(2):146-53. doi: 10.1111/1756-185X.12490. Review.

PMID:
25884458
10.

Biologics in SLE: the current status.

Rajadhyaksha AG, Mehra S, Nadkar MY.

J Assoc Physicians India. 2013 Apr;61(4):262-7.

PMID:
24482965
11.

[Biological therapies in systemic lupus erythematosus].

Cairoli E, Espinosa G, Cervera R.

Rev Med Chil. 2010 Jul;138(7):881-7. Review. Spanish.

PMID:
21043085
12.

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L.

Ann Rheum Dis. 2010 Jul;69(7):1269-74. doi: 10.1136/ard.2009.117200. Epub 2009 Nov 5.

13.

[Recommendation for use of belimumab for systemic lupus erythematosus].

Fischer-Betz R, Schneider M; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2013 Jun;72(5):462-7. doi: 10.1007/s00393-013-1212-z. German.

PMID:
23695423
14.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Ann Rheum Dis. 2008 Feb;67(2):195-205. Epub 2007 May 15.

15.

Upcoming biological therapies in systemic lupus erythematosus.

Sciascia S, Talavera-Garcia E, Roccatello D, Baldovino S, Mengatti E, Cuadrado MJ.

Int Immunopharmacol. 2015 Aug;27(2):189-93. doi: 10.1016/j.intimp.2015.04.049. Epub 2015 May 28. Review.

16.

Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.

Petri M, Bechtel B, Dennis G, Shah M, McLaughlin T, Kan H, Molta C.

Lupus. 2014 Sep;23(10):1006-13. doi: 10.1177/0961203314532699. Epub 2014 Apr 30.

PMID:
24786783
17.

Recent progress in conventional and biologic therapy for systemic lupus erythematosus.

Wofsy D.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii66-8. doi: 10.1136/annrheumdis-2012-202204. Epub 2012 Dec 19. Review.

PMID:
23253930
18.

[Biologics therapy for systemic lupus erythematosus. Current situation].

Hoyer BF, Dörner T.

Z Rheumatol. 2015 Apr;74(3):206-14. doi: 10.1007/s00393-014-1458-0. Review. German.

PMID:
25854155
19.

In-/off-label use of biologic therapy in systemic lupus erythematosus.

Gatto M, Kiss E, Naparstek Y, Doria A.

BMC Med. 2014 Feb 17;12:30. doi: 10.1186/1741-7015-12-30. Review.

20.

Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.

Medina-Rosas J, Al-Rayes H, Moustafa AT, Touma Z.

Expert Opin Biol Ther. 2016 Oct;16(10):1225-38. doi: 10.1080/14712598.2016.1214263. Epub 2016 Jul 29. Review.

PMID:
27429254

Supplemental Content

Support Center